DIVERSITY, EQUITY, AND INCLUSION
You are the CEO of a large, publicly traded firm based in the US in the pharmaceutical sector. Your organization is performing relatively well, today. That said, your firm has two major revenue generating products, which will lose patent protection in the U.S. over the next 3 years. Wall Street recently evaluated your R&D portfolio as barely above industry average for risk adjusted NV. You are not immune to unforeseen events including clinical failures or FDA delays. The Board of Directors and shareholders have expressed concern about the general lack of diversity in the organization and that the lack of diversity is more prominent as you move up the organizational chart. Indeed, the C-Suite is almost entirely composed of heterosexual, White males from affluent backgrounds.
First, using course content, describe what likely caused this situation to occur and what implications (positive or negative) that might affect a highly homogenous organization. Develop an action plan that will detail how you will attract, select, retain, and promote a diverse workforce.
